Literature DB >> 9682310

Magnetic resonance imaging of experimental subacute spinal cord compression.

M Fukuoka1, N Matsui, T Otsuka, M Murakami, Y Seo.   

Abstract

STUDY
DESIGN: Subacute compression of the spinal cord was applied to rats. The animals were chronologically observed using magnetic resonance imaging for more than 8 weeks after surgery and were killed for histopathologic examination.
OBJECTIVES: To investigate the correlation of changes in signal intensity on magnetic resonance images with those observed in histopathologic study and with the degree of spinal cord compression and paralysis. SUMMARY OF BACKGROUND DATA: No consensus has been reached concerning the correlation of magnetic resonance images to clinical symptoms of compressive myelopathy. Few reports are available in which magnetic resonance imaging findings are compared with histopathologic features in chronic or subacute experiments.
METHODS: In rats under general anesthesia, the T11 lamina was thinned and a slow increase in volume was applied. Hind limb paralysis appeared 1 week after the procedure and spontaneously subsided thereafter. The degree of spinal compression and signal intensity was observed chronologically using magnetic resonance imaging. The signal intensity on the final MR images was rated on a four-point scale and compared with histopathologic findings.
RESULTS: As spinal compression increased, the incidence of high signal intensity on long spin-echo images became higher. Low signal intensities on short spin-echo images were visible in animals in which compression and paralysis were the most severe. In these animals, cavitation and a dilated central canal were visible. High signal intensities on long spin-echo images reflected various pathologic changes.
CONCLUSIONS: Changes in signal intensity on MR images are visible after the induction of myelopathy by high-pressure compression. These signal intensities may be useful in predicting the outcome of compressive myelopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9682310     DOI: 10.1097/00007632-199807150-00008

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Percutaneous translumbar spinal cord compression injury in a dog model that uses angioplasty balloons: MR imaging and histopathologic findings.

Authors:  Phillip D Purdy; Robert T Duong; Charles L White; Donna L Baer; R Ross Reichard; G Lee Pride; Christina Adams; Susan Miller; Christa L Hladik; Zerrin Yetkin
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

2.  In vivo high-resolution MR imaging of neuropathologic changes in the injured rat spinal cord.

Authors:  T Weber; M Vroemen; V Behr; T Neuberger; P Jakob; A Haase; G Schuierer; U Bogdahn; C Faber; N Weidner
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 3.  Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research.

Authors:  Daniel Lammertse; David Dungan; James Dreisbach; Scott Falci; Adam Flanders; Ralph Marino; Eric Schwartz
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

4.  Combination of serum phosphorylated neurofilament heavy subunit and hyperintensity of intramedullary T2W on magnetic resonance imaging provides better prognostic value of canine thoracolumbar intervertebral disc herniation.

Authors:  Tadahisa Mashita; Hiroaki Kamishina; Yuya Nakamoto; Yosuke Akagi; Ataru Nakanishi; Yusuke Harasaki; Tsuyoshi Ozawa; Takashi Uemura; Yui Kobatake; Shunsuke Shimamura; Naoki Kitamura; Sadatoshi Maeda; Yuji Uzuka; Gerry Shaw; Jun Yasuda
Journal:  J Vet Med Sci       Date:  2014-12-19       Impact factor: 1.267

Review 5.  Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging.

Authors:  Gergely David; Siawoosh Mohammadi; Allan R Martin; Julien Cohen-Adad; Nikolaus Weiskopf; Alan Thompson; Patrick Freund
Journal:  Nat Rev Neurol       Date:  2019-10-31       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.